2022 Cannabis Extraction Virtual Conference: September Program
Sponsored by Vanguard Scientific
Click here to see all available CIJ events and webinars
Agenda
Solvent Remediation – The Last Step for Safe, Clean Hemp Extraction
- Tom Bisbee, Production Director, EcoGen Biosciences
Attendees can expect to learn:
- Understanding solvent remediation technology and processes
- Residual solvents present huge risks
- Consumers deserve transparency
Advancing Cannabinoid Therapeutics Through Regulated Drug Discovery
- Matthew Anderson, CEO, Vanguard Scientific
- Nick Herbst, VP of Engineering, Vanguard Scientific
- Brian Brandley, Ph.D., Laboratory Director, Biopharmaceutical Research Co.
A panel discussion with Dr. Brian Brandley, the CSO of Biopharmaceutical Research Company, a DEA-licensed pharmaceutical company that is pioneering the legal cannabis space in the U.S. through the development of federally compliant active pharmaceutical ingredients (API) for plant-based therapeutics, and Nick Herbst, VP of Engineering at Vanguard Scientific, and the Lead Engineer for the Company’s MIDAS SCCO2 Extraction Program. During this 45-minute round table discussion moderated by Vanguard’s CEO Matthew Anderson, the panelists will provide an overview of what it takes to make ‘pharmaceutical-grade’ cannabis products. The conversation will range from facility requirements, methods development, equipment qualification, process validations and more.
GMPs for Cannabis Extraction: Don’t Overcomplicate it
- Andrew Cole, Director, Client Delivery Audits, Cannon Quality Group
Attendees can expect to learn:
- Understanding the basics in plain English.
- Learn what you need to do to meet minimum Industry expectations for Quality and Scalability.
- Implementation Strategies – Keep it simple.
